Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Prelević
G M
GM
Zvezdara University Medical Center, Belgrade University School of Medicine, Yugoslavia.
Puzigaća
Z
Z
Balint-Perić
L A
LA
D000328:Adult; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000728:Androgens / Q000097:blood*; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use*; D017373:Cyproterone Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006628:Hirsutism / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D010053:Ovary / Q000473:pathology*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy* / Q000503:physiopathology
D000726:Androgen Antagonists; D000728:Androgens; D003276:Contraceptives, Oral; D004338:Drug Combinations; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination; D007986:Luteinizing Hormone